Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: A meta-analysis

Oral Oncology

Volumn 48, Issue 11, 2012, Pages 1076-1084

  Ma, Jie ^a   Liu, Ying ^a   Huang, Xiao Lu ^a   Zhang, Zhi Yuan ^a   Myers, Jeffrey N ^b   Neskey, David M ^b   Zhong, Lai Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Head and neck squamous cell carcinoma; Induction chemotherapy; Meta analysis; Prognosis

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; METHOTREXATE;

ANALOG DIGITAL CONVERTER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISTANT METASTASIS; HAZARD RATIO; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; KAPLAN MEIER METHOD; LEUKOPENIA; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; META ANALYSIS; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION INDUCED EMESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SKIN TOXICITY; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84867881896     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.06.014     Document Type: Review

References (65)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. A.A. Forastiere Head and neck cancer: overview of recent developments and future directions Semin Oncol 27 2000 1 4
3. R.M.M. Pratt, T.J. Betteridge, and P. Dixon Regional arterial cytotoxic perfusion combined with radical operation in breast cancer Br J Surg 50 1963 833 837
4. C.F. Von Essen, L.B.M. Joseph, G.T. Simon, A.D. Singh, and S.P. Singh Sequential chemotherapy and radiation therapy of buccal mucosa carcinoma in South India: methods and preliminary results Am J Radiol 102 1968 530 540
5. F.O. Stephens Intra-arterial perfusion of the chemotherapeutic agents Methotrexate and Epodyl in patients with advanced localised carcinomata recurrent after radiotherapy Aust NZ J Surg 39 1970 371 379
6. J.P. Pignon, J. Bourhis, C. Domenge, and L. Designé Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Lancet 355 2000 949 955
7. J.P. Pignon, A. le Maître, E. Maillard, and J. Bourhis MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
8. M. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
9. R.P. Williamson, T.C. Smith, L.J. Hutton, and A.G. Marson Aggregate data meta-analysis with time-to-event outcome Stat Med 21 2002 3337 3351
10. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
11. T. Mitsudomi, N. Hamajima, M. Ogawa, and T. Takahashi Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis Clin Cancer Res 6 2000 4055 4063
12. J. Depondt, P. Gehanno, M. Martin, G. Lelievre, B. Guerrier, and C. Peytral Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer Oncology 50 1993 23 27
13. B. Luboinski, C. Domenge, R. Lancar, B. Coche-Dequean, A. Lusinchi, and J.L. Lefebvre Induction chemotherapy before radiotherapy in oropharyngeal carcinoma: a randomized trial Eur J Cancer 31A 1995 S86
14. Y. Hasegawa, H. Matsuura, M. Fukushima, M. Kano, and K. Shimozato Potential suppression of distant and node metastasis by neoadjuvant chemotherapy in advanced head and neck cancer: result of a randomized trial Proc ASCO 15 1996 318
15. A. Paccagnella, A. Orlando, C. Marchiori, P.L. Zorat, G. Cavaniglia, and V.C. Sileni Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo J Natl Cancer Inst 86 1994 265 272
16. P.L. Zorat, A. Paccagnella, G. Cavaniglia, L. Loreggian, A. Gava, and C.A. Mione Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up J Natl Cancer Inst 96 2004 1714 1717
17. M. Tejedor, A. Murias, P. Soria, J. Aguiar, J. Salinas, and M.A. Hernandez Induction chemotherapy with carboplatin and ftorafur in advanced head and neck cancer. A randomized study Am J Clin Oncol 15 1992 417 421
18. P. Volling, M. Schröder, R.P. Müller, O. Ebeling, R. Quirin, and E. Stennert Induction chemotherapy in primary resectable head and neck tumors:a prospective randomized trial Int J Oncol 4 1994 909 914
19. F. Lewin, L. Damber, H. Jonsson, T. Andersson, A. Berthelsen, and A. Biörklund Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study Radiother Oncol 43 1997 23 28
20. R.J. Toohill, T. Anderson, R.W. Byhardt, J.D. Cox, J.A. Duncavage, and T.W. Grossman Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report Arch Otolaryngol Head Neck Surg 113 1987 758 761
21. C. Domenge, C. Hill, J.L. Lefebvre, D. De Raucourt, B. Rhein, and P. Wibault Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC) Br J Cancer 83 2000 1594 1598
22. L. Licitra, C. Grandi, M. Guzzo, L. Mariani, S. Lo Vullo, and F. Valvo Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial J Clin Oncol 21 2003 327 333
23. P. Gehanno, J. Depondt, R. Peynegre, C. Peytral, M. Martin, and F. Baillet Neoadjuvant combination of carblplatin and 5-FU in head and neck cancer: a randomized study Ann Oncol 3 1992 S43 46
24. F. Brunin, J. Rodriguez, C. Jaulerry, M. Jouve, D. Pontvert, and D. Point Induction chemotherapy in advanced head and neck cancer. Preliminary results of a randomized study Acta Oncol 28 1989 61 65
25. C. Jaulerry, J. Rodriguez, F. Brunin, M. Jouve, V. Mosseri, and D. Point Induction chemotherapy in advanced head and neck tumors: results of two randomized trials Int J Radiat Oncol Biol Phys 23 1992 483 489
26. W.N. Pearlman, B.F. Johnson, J.T. Braun, R.C. Kennaugh, B.F. Spofford, and B.C. Borlase A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced or recurrent oral/pharyngeal squamous carcinoma Am J Clin Oncol 8 1985 490 496
27. Final report of the Head and Neck Contracts Program Adjuvant chemotherapy for advanced head and neck squamous carcinoma Cancer 60 1987 301 311
28. C. Jacobs, and R. Makuch Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the head and neck contracts program J Clin Oncol 8 1990 838 847
29. T. Maipang, M. Maipang, A. Geater, C. Panjapiyakul, S. Watanaarepornchai, and S. Punperk Combination chemotherapy as induction therapy for advanced resectable head and neck cancer J Surg Oncol 59 1995 80 85
30. J.J. Mazeron, M. Martin, B. Brun, L. Grimard, G. Lelièvre, and L. Vergnes Induction chemotherapy in head and neck cancer: results of a phase III trial Head Neck 14 1992 85 91
31. J.V. Salvajoli, H. Morioka, N. Trippe, and L.P. Kowalski A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 249 1992 211 215
32. L.A. Carvalho, V.J. Salvajoli, and P.L. Kowalski A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas Eur Arch Otorhinolaryngol 257 2000 164 167
33. D.E. Schuller, B. Metch, D.W. Stein, D. Mattox, and J.D. McCracken Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group Laryngoscope 98 1988 1205 1211
34. N. Kohno, T. Ikari, M. Kawaida, K. Tanaka, M. Kawaura, and S. Kano Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck Jpn J Clin Oncol 30 2000 253 258
35. P.Y. Holoye, T.W. Grossman, R.J. Toohill, L.E. Kun, R.W. Byhardt, and J.A. Duncavage Randomized study of adjuvant chemotherapy for head and neck cancer Otolaryngol Head Neck Surg 93 1985 712 717
36. E.L. Kun, J.R. Toohill, Y.P. Holoye, J.A. Duncavage, R.W. Byhardt, and P.S. Ritch A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract Int J Radiat Oncol Biol Phys 12 1986 173 178
37. A. Jortay, F. Demard, O. Dalesio, C. Blanchet, A. Desaulty, and C. Gehanno A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years Acta Chir Belg 90 1990 115 122
38. M.J. Richard, A. Kramar, R. Molinari, J.L. Lefebvre, F. Blanchet, and A. Jortay Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma Eur J Cancer 27 1991 821 827
39. Z.M. Siodlak, E.J. Dalby, J.P. Bradley, J.B. Campbell, P. Strickland, and J.G. Fraser Induction VBM plus radiotherapy, versus radiotherapy alone for advanced head and neck cancer: long-term results Clin Otolaryngol Allied Sci 14 1989 17 22
40. C. Stolwijk, T.J.D. Wagener, P. Van Den Broek, P.C. Levendag, I. Kazem, and I. Bruaset Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer Neth J Med 28 1985 347 351
41. T.J. Fazekas, C. Sommer, and S. Kramer Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx Int J Radiat Oncol Biol Phys 6 1980 533 541
42. S. Kramer Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx. (Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group) Can J Otolaryngol 4 1975 213 218
43. M.J. Richard, H. Sancho, Y. Lepintre, J. Rodary, and B. Pierquin Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx Cancer 34 1974 491 496
44. H.A. KnowUon, B. Percarpio, S. Bobrow, and J.J. Fischer Methotrexate and radiation therapy in the treatment of advanced head and neck tumors Radiology 116 1975 709 712
45. S.G. Taylor 4th, E. Applebaum, J.L. Showel, M. Norusis, L.D. Holinger, and J.C. Hutchinson Jr. A randomized trial of adjuvant chemotherapy in head and neck cancer J Clin Oncol 3 1985 672 679
46. S. Kumar, N.R. Datta, R.C. Ahuja, H.R. Mali, G.N. Agarwal, and S. Ayyagari Feasibility of non-cisplatin-based induction chemotherapy and concurrent chemoradiotherapy in advanced head and neck cancer Acta Oncol 35 1996 721 725
47. S.G. Taylor 4th, A.K. Murthy, J.M. Vannetzel, P. Colirn, M. Dray, and D.D. Caldarelli Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer J Clin Oncol 12 1994 385 395
48. M. Merlano, R. Corvo, G. Margarino, M. Benasso, R. Rosso, and M.R. Sertoli Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial Cancer 67 1991 915 921
49. M. Merlano, R. Rosso, R.M. Sertoli, M. Benasso, A. Bacigalupo, and A. Ardizzoni Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck Laryngoscope 100 1990 531 535
50. An interim report from the SECOG participants A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck Eur J Surg Oncol 12 1986 289 295
51. A. Paccagnella, L. Loreggian, A. Buffoli, A. Buffoli, H. Koussis, and C.A. Mione Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study Ann Oncol 21 2010 1515 1522
52. R. Hitt, J.J. Grau, A. Lopez-Pousa, A. Berrocal, C.G. Giron, and A. Irigoyen Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC) J Clin Oncol 27 2009 15s
53. J.L. Lefebvre, D. Chevalier, B. Luboinski, A. Kirkpatrick, L. Collette, and T. Sahmoud Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 1996 890 899
54. J.M. Richard, H. Sancho-Garnier, J.J. Pessey, B. Luboinski, J.L. Lefebvre, and D. Dehesdin Randomized trial of induction chemotherapy in larynx carcinoma Oral Oncol 34 1998 224 228
55. The Department of Veterans Affairs Laryngeal Cancer Study Group Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1991 1685 1690
56. J.E. Terrell, S.G. Fisher, and G.T. Wolf Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group Arch Otolaryngol Head Neck Surg 124 1998 964 971
57. L.J. Lefebvre, F. Rolland, M. Tesselaar, E. Bardet, C.R. Leemans, and L. Geoffrois Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy J Natl Cancer Inst 101 2009 142 152
58. M.J. Prades, B. Lallemant, R. Garrel, E. Reyt, C. Righini, and T. Schmitt Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma Acta Otolaryngol 130 2010 150 155
59. R.M. Posner, M.D. Hershock, R.C. Blajman, E. Mickiewicz, E. Winquist, and V. Gorbounova Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
60. B.J. Vermorken, E. Remenar, V.C. Herpen, T. Gorlia, R. Mesia, and M. Degardin Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
61. J.H. Lorch, O. Goloubeva, R.I. Haddad, K. Cullen, N. Sarlis, and R. Tishler Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial Lancet Oncol 12 2011 153 159
62. R.B. Tishler, P.B. Schiff, C.R. Geard, C.R. Geard, and E.J. Hall Taxol: a novel radiation sensitizer Int J Radiat Oncol Biol Phys 22 1992 613 617
63. L. Milas, Y. Saito, N. Hunter, C.G. Milross, and K.A. Mason Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma Radiother Oncol 40 1996 163 170
64. C.X. Geng, Z.C. Zeng, J.Y. Wang, S.Y. Xuan, and C.M. Lin Docetaxel shows radiosensitization in human hepatocellular carcinoma cells World J Gastroenterol 11 2005 2990 2993
65. S. Temam, A. Flahault, S. Périé, G. Monceaux, F. Coulet, and P. Callard P53 Gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck J Clin Oncol 18 2000 385 394